OILHealth CareCompany Update1 Sept 20261 September 2026· 2 min read
Optiscan Imaging (ASX: OIL) Starts US Head and Neck Cancer Study
Optiscan has begun recruiting patients for a Mayo Clinic head and neck cancer study. Data will support planned US FDA submissions for InVue and InForm later in 2026.